Insmed Incorporated

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. 

CEO
William H. Lewis
CEOWilliam H. Lewis
Employees
1,664
Employees1,664
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
1988
Founded1988
Employees
1,664
Employees1,664

INSM Key Statistics

Market cap
23.29B
Market cap23.29B
Price-Earnings ratio
-18.70
Price-Earnings ratio-18.70
Dividend yield
Dividend yield
Average volume
2.25M
Average volume2.25M
High today
$107.85
High today$107.85
Low today
$105.09
Low today$105.09
Open price
$105.80
Open price$105.80
Volume
1.74M
Volume1.74M
52 Week high
$212.75
52 Week high$212.75
52 Week low
$90.39
52 Week low$90.39

Stock Snapshot

With a market cap of 23.29B, Insmed Incorporated(INSM) trades at $107.41. The stock has a price-to-earnings ratio of -18.70.

During the trading session on 2026-07-24, Insmed Incorporated(INSM) shares reached a daily high of $107.85 and a low of $105.09. At a current price of $107.41, the stock is +2.2% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 1.74M, compared to an average daily volume of 2.25M.

Over the past 52 weeks, Insmed Incorporated(INSM) stock has traded between a high of $212.75 and a low of $90.39.

Over the past 52 weeks, Insmed Incorporated(INSM) stock has traded between a high of $212.75 and a low of $90.39.

INSM News

Simply Wall St 1d
Healthcare Stocks to Watch If Social Security Checks Get Bigger

Retirees could see bigger Social Security checks if policymakers adopt the R-CPI-E inflation measure, and that potential shift has put healthcare stocks under a...

Healthcare Stocks to Watch If Social Security Checks Get Bigger
Simply Wall St 2d
Insmed Stock Could Be Pricey As Its 4.4x Run Continues - simplywall.st

...

Insmed Stock Could Be Pricey As Its 4.4x Run Continues - simplywall.st
TipRanks 3d
Ritu Baral Reaffirms Buy on Insmed, Raising Price Target from $200 to $243 Ahead of Q2 Preview

Insmed, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Ritu Baral from TD Cowen maintained a Buy rating on the stock a...

Analyst ratings

100%

of 25 ratings
Buy
100%
Hold
0%
Sell
0%

More INSM News

TipRanks 4d
Insmed initiated with an Outperform at BMO Capital

BMO Capital analyst Conor MacKay initiated coverage of Insmed (INSM) with an Outperform rating and $192 price target The firm’s positive view is based on Brinsu...

TipRanks 7d
Insmed: TPIP’s Strong Durability and Risk‑Benefit Profile Support Buy Rating and Unchanged $212 Price Target

Analyst Maxwell Skor from Morgan Stanley maintained a Buy rating on Insmed and keeping the price target at $212.00. TipRanks has entered a new arena in the inv...

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.